TP53 and cancer: PRIMA-1 (p53-reactivation and induction of massive apoptosis-1), a low molecular weight compound (C9H15NO3), was discovered to restore the mutant p53 to the structure and function of wild-type p53, thus selectively killing cancer cells with mutant p53 [17].